{"TopicDetails": {"type": 0, "ccm2Id": 31065390, "cftId": 0, "identifier": "IMI2-2015-03-05", "title": "Pertussis vaccination research", "publicationDateLong": 1418774400000, "callIdentifier": "H2020-JTI-IMI2-2015-03-two-stage", "callTitle": "IMI2 3rd Call for Proposals", "callccm2Id": 31067006, "allowPartnerSearch": true, "frameworkProgramme": {"id": 31045243, "abbreviation": "H2020", "description": "Horizon 2020 Framework Programme"}, "programmeDivision": [{"id": 31047894, "abbreviation": "EU.3.1.", "description": "Health, demographic change and wellbeing"}, {"id": 31047893, "abbreviation": "EU.3.", "description": "Societal Challenges"}, {"id": 31062059, "abbreviation": "EU.3.1.7.", "description": "Innovative Medicines Initiative 2 (IMI2)"}, {"id": 31045244, "abbreviation": "EC", "description": "EC Treaty"}, {"id": 31062071, "abbreviation": "EU.3.1.7.12.", "description": "Vaccine"}], "topicMGAs": [], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "IMI2-RIA Research and Innovation action", "typeOfMGA": []}], "plannedOpeningDate": "17 December 2014", "submissionProcedure": {"id": 31094505, "abbreviation": "two-stage", "description": "two-stage"}, "deadlineDates": ["24 March 2015", "29 September 2015"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3206648": [{"action": "IMI2-2015-03-01 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "17 December 2014", "deadlineModel": "two-stage", "deadlineDates": ["24 March 2015", "29 September 2015"], "budgetYearMap": {"0": 112860000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-03-06 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "17 December 2014", "deadlineModel": "two-stage", "deadlineDates": ["24 March 2015", "29 September 2015"], "budgetYearMap": {"0": 112860000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-03-05 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "17 December 2014", "deadlineModel": "two-stage", "deadlineDates": ["24 March 2015", "29 September 2015"], "budgetYearMap": {"0": 112860000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-03-03 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "17 December 2014", "deadlineModel": "two-stage", "deadlineDates": ["24 March 2015", "29 September 2015"], "budgetYearMap": {"0": 112860000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-03-04 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "17 December 2014", "deadlineModel": "two-stage", "deadlineDates": ["24 March 2015", "29 September 2015"], "budgetYearMap": {"0": 112860000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2015-03-02 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "17 December 2014", "deadlineModel": "two-stage", "deadlineDates": ["24 March 2015", "29 September 2015"], "budgetYearMap": {"0": 112860000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["0"]}, "description": "<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p><u>Specific Challenge</u> </p><p>Despite the success and relatively large vaccination coverage with pertussis vaccines in industrialised countries, pertussis remains one of the leading causes of vaccine-preventable deaths world-wide, and there has been resurgence of pertussis incidents in certain countries that calls for action.</p><p><u>Scope</u> </p><p>The scope of the topic comprises investigations into the differences between whole cell and acellular pertussis vaccines, in particular with regards to their ability to generate protection against infection, disease, carriage\u00a0 and transmission, as well as with regards to establishing long term immunological memory, and the role of maternal antibody in modulating immune responses to pertussis vaccination in infants</p><p><u>Expected Impact</u> </p><p>The knowledge acquired will be useful in understanding the reasons underlying the resurgence of pertussis disease in school age children, adolescents, and younger adults and ultimately provide clues as to how current vaccines and vaccination schedules can be modified to enhance protection in these populations as well as at-risk populations globally.</p><p><u>Budget</u> </p><p>\u00a0IMI contribution:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EUR 14 000 000</p><p>EFPIA contribution:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EUR 7 000 000</p><p>IMI2 JU Associated Partners\u2019 contribution: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EUR 7 000 000</p><p>Total: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EUR 28 000 000</p>\n", "conditions": "<p>Please read the IMI2 3rd Call Topics Text for full details of this topic, including the budget breakdown.<br />\r\nPlease note that submitting proposals for this call can only be done through the IMI SOFIA software tool.</p>\r\n<p>Please read carefully all provisions below before the preparation of your application.</p>\r\n<ol>\r\n    <li>List of countries and applicable rules for funding:<br />\r\n    described in article 10(2) of Regulation N&deg; 1290/2013 of 11 December 2013 laying down the rules for participation and dissemination in Horizon 2020 and in article 1 of the Commission Delegated Regulation (EU) N&deg; 622/2014 of 14 February 2014<br />\r\n    &nbsp;</li>\r\n    <li>Eligibility and admissibility conditions:<br />\r\n    described in the IMI2 Manual for evaluation, submission and grant award. See also the Commission Delegated Regulation (EU) N&deg; 622/2014 of 14 February 2014<br />\r\n    &nbsp;</li>\r\n    <li>Evaluation<br />\r\n    Guide to the submission and evaluation process including evaluation criteria and procedure, scoring and threshold:<br />\r\n    described in the IMI2 Manual for submission, evaluation and grant award.<br />\r\n    See also the proposal templates for your specific action in section 6, below.<br />\r\n    &nbsp;</li>\r\n    <li>Proposal page limits and layout:<br />\r\n    Please refer to the proposal templates for your specific action, see section 6, below.<br />\r\n    &nbsp;</li>\r\n    <li>Indicative timetable for evaluation and grant agreement:<br />\r\n    Notification of outcomes of Stage 1 evaluations: Maximum 5 months from deadline for submitting proposals<br />\r\n    Notification of outcomes of Stage2 evaluations: Maximum 5 months from deadline for submitting full proposals<br />\r\n    Signature of grant agreements: maximum 3 months from the date of informing successful applicants.<br />\r\n    &nbsp;</li>\r\n    <li>Provisions, proposal templates and evaluation forms<br />\r\n    IMI2 Model Grant Agreement<br />\r\n    Summary of the most relevant provisions for participating in IMI2 actions<br />\r\n    IMI2 RIA/IA Proposal template<br />\r\n    IMI2 RIA/IA Evaluation form<br />\r\n    Template for essential clinical trial information</li>\r\n</ol>", "supportInfo": "<div>\r\n<p>Contact the <strong>IMI Programme Office</strong>. E-mail: <a href=\"mailto:Infodesk@imi.europa.eu\"><strong>Infodesk@imi.europa.eu</strong></a>&nbsp;&nbsp;Tel.: +32 2 221 8181</p>\r\n<p><a href=\"mailto:sofia@imi.europa.eu\"><strong>IT Helpdesk</strong></a> - contact the SOFIA IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.</p>\r\n<p><a href=\"http://www.imi.europa.eu/content/states-representatives-groups\"><strong>IMI2 States Representative Group (SRG)</strong></a>&nbsp;- contact your SRG&nbsp;member for assistance</p>\r\n<p><span><a href=\"http://www.imi.europa.eu/content/partner-search\"><strong>IMI Partner Search Tool</strong></a> helps you find a partner organisation for your proposal</span></p>\r\n<p><span><a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/support/national_contact_points.html\"><strong>National Contact Points (NCP)</strong></a></span></p>\r\n<p><span><a href=\"http://een.ec.europa.eu/\"><strong>Enterprise Europe Network</strong></a> &ndash; national contact points' advice to businesses with focus on SMEs. The support includes guidance on the EU research funding.</span></p>\r\n<p><a href=\"http://ec.europa.eu/research/index.cfm?lg=en&amp;pg=enquiries\"><strong>Research Enquiry Service</strong></a> &ndash; ask questions about any aspect of European research and EU R&amp;I programmes</p>\r\n<p><strong>Ethics</strong> &ndash; for compliance with ethical issues, see the <a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/ethics_en.htm\">Participant Portal</a>&nbsp;and&nbsp;<a href=\"http://ec.europa.eu/research/science-society/index.cfm?fuseaction=public.topic&amp;id=1289&amp;lang=1\">Science and Society Portal</a></p>\r\n<p><a href=\"http://ec.europa.eu/euraxess/pdf/brochure_rights/am509774CEE_EN_E4.pdf\"><strong>The European Charter for Researchers and the Code of Conduct for their recruitment</strong></a></p>\r\n<p><a href=\"http://www.cen.eu/cen/Services/Innovation/Pages/default.aspx\"><strong>CEN</strong></a> and <a href=\"http://www.cenelec.eu/aboutcenelec/whatwestandfor/fosterinnovation/randd.html\"><strong>CENELEC</strong></a>, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at <a href=\"mailto:research@cencenelec.eu\">research@cencenelec.eu</a>.</p>\r\n</div>", "sepTemplate": "<p>To access the Electronic Submission Service of the topic, please select the <strong>type of action</strong> that is most relevant to your proposal from the list below and click on the <strong>'Start Submission' </strong>button. You will then be asked to confirm your choice of the type of action, the topic for the call, as these cannot be changed subsequently in the submission system. Upon confirmation you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Participant Portal and select the My Proposals page of the My Area section.</p>", "links": [{"callIdentifier": "H2020-JTI-IMI2-2015-03-two-stage", "status": "Closed", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "IMI2-RIA-IA", "criterionDescription": "(Research and) Innovation action", "url": "https://sofia.imi.europa.eu/", "startDate": "Jan 15, 2015 5:35:00 PM"}], "additionalDossiers": [], "infoPackDossiers": [{"callId": 6752, "id": 7780, "title": "IMI2 Call 3 Text", "sectionId": 6752, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 870711, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-05/1635145-imi2_call-3_text_en.pdf", "id": 1635145, "fileName": "IMI2_Call-3_Text_en.pdf", "common": false, "crc32": 4035280651}]}, {"callId": 6752, "id": 7785, "title": "IMI2 Call 3 - General Conditions", "sectionId": 6752, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 224364, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-05/1635141-generalconditionsforthecall_en.pdf", "id": 1635141, "fileName": "GeneralConditionsfortheCall_en.pdf", "common": false, "crc32": 993791134}]}, {"callId": 6752, "id": 7770, "title": "Summary of the most relevant provisions for participating in IMI2 actions", "sectionId": 6752, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 177193, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-05/1635134-imi2_summary_of_most_relevant_provisions_for_participating_in_imi2_actions_en.pdf", "id": 1635134, "fileName": "IMI2_Summary of most relevant provisions for participating in IMI2 actions_en.pdf", "common": false, "crc32": 1929684055}]}, {"callId": 6752, "id": 7765, "title": "IMI2 Manual for Submission, Evaluation, and Grant Award", "sectionId": 6752, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 546419, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-05/1635132-imi2_manual_for_submission_evaluation_grant_award_en.pdf", "id": 1635132, "fileName": "IMI2_Manual_for_submission_evaluation_grant award_en.pdf", "common": false, "crc32": 1572805413}]}, {"callId": 6752, "id": 7755, "title": "IMI2 RIA/IA Proposal Template (doc)", "sectionId": 6752, "translationFiles": [{"language": "en", "mimeType": "application/msword", "fileSize": 599040, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-05/1635129-imi2_proposal-template_ria-ia_en.doc", "id": 1635129, "fileName": "IMI2_Proposal-Template_RIA-IA_en.doc", "common": false, "crc32": 1032474637}]}, {"callId": 6752, "id": 7750, "title": "IMI2 RIA/IA Proposal Template (pdf)", "sectionId": 6752, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 194840, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-05/1635128-imi2_proposal-template_ria-ia_en.pdf", "id": 1635128, "fileName": "IMI2_Proposal-Template_RIA-IA_en.pdf", "common": false, "crc32": 2865859008}]}, {"callId": 6752, "id": 7760, "title": "IMI2 RIA/IA Evaluation Form", "sectionId": 6752, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 102685, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-05/1635130-imi2_evaluation-form_ria-ia_en.pdf", "id": 1635130, "fileName": "IMI2_Evaluation-Form_RIA-IA_en.pdf", "common": false, "crc32": 2170438193}]}, {"callId": 6752, "id": 7775, "title": "IMI2 Model Grant Agreement", "sectionId": 6752, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 1165682, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-03-05/1635133-imi_2_mga_2014.07.04_en.pdf", "id": 1635133, "fileName": "IMI_2_MGA_2014.07.04_en.pdf", "common": false, "crc32": 1898683111}]}], "callDetailsJSONItem": {"additionalInfo": "<p>For full information on this call, please refer to the <a href=\"http://www.imi.europa.eu/content/stage-1-14\">Call 3 section of the&nbsp;IMI website.</a></p>\r\n<p>Please note that submitting short proposals for this call can only be done through the <a href=\"https://sofia.imi.europa.eu/Pages/Default.aspx\">IMI SOFIA software tool</a><br />\r\n&nbsp;</p>", "latestInfos": [{"approvalDate": "Mar 9, 2015 2:57:46 PM", "lastChangeDate": "Mar 9, 2015 2:57:18 PM", "content": "<p>Deadline for submission approaching: <span style=\"color: #ff0000\"><strong>24 March 2015 17:00</strong></span> Brussels time</p>\r\n<p><a href=\"http://www.imi.europa.eu/events/2014/12/05/webinars-imi2-calls-3-and-4\">Webinar presentations</a> for all topics now available.</p>"}, {"approvalDate": "Jan 15, 2015 5:56:23 PM", "lastChangeDate": "Jan 15, 2015 5:56:23 PM", "content": "The submission session is now available for: IMI2-2015-03-01(IMI2-RIA-IA), IMI2-2015-03-02(IMI2-RIA-IA), IMI2-2015-03-03(IMI2-RIA-IA), IMI2-2015-03-04(IMI2-RIA-IA), IMI2-2015-03-05(IMI2-RIA-IA), IMI2-2015-03-06(IMI2-RIA-IA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}